Stony Brook Medicine is the first on Long Island — and one of a select number of healthcare systems nationwide — to implement an artificial intelligence technology, HeartFlow Plaque Analysis™, to enable its physicians to more accurately understand the blockages present in the coronary arteries of patients with suspected heart disease.
